1. Home
  2. MCBS vs SLDB Comparison

MCBS vs SLDB Comparison

Compare MCBS & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MetroCity Bankshares Inc.

MCBS

MetroCity Bankshares Inc.

HOLD

Current Price

$36.17

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$8.42

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCBS
SLDB
Founded
2006
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2019
2017

Fundamental Metrics

Financial Performance
Metric
MCBS
SLDB
Price
$36.17
$8.42
Analyst Decision
Hold
Strong Buy
Analyst Count
1
11
Target Price
$33.00
$16.36
AVG Volume (30 Days)
91.3K
2.6M
Earning Date
04-24-2026
05-12-2026
Dividend Yield
3.63%
N/A
EPS Growth
4.76
34.97
EPS
0.77
N/A
Revenue
N/A
$8,094,000.00
Revenue This Year
$36.78
N/A
Revenue Next Year
$2.44
N/A
P/E Ratio
$47.03
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.53
$3.79
52 Week High
$37.46
$11.45

Technical Indicators

Market Signals
Indicator
MCBS
SLDB
Relative Strength Index (RSI) 54.97 41.82
Support Level $33.81 $6.38
Resistance Level $37.46 $8.87
Average True Range (ATR) 1.15 0.59
MACD -0.07 -0.33
Stochastic Oscillator 49.84 5.18

Price Performance

Historical Comparison
MCBS
SLDB

About MCBS MetroCity Bankshares Inc.

MetroCity Bankshares Inc is a bank holding company. Through its banking subsidiary, it operates as a full-service commercial bank focused on delivering various financial products and services to the small-to medium-sized businesses and individuals in its markets, including many customers in diverse and multi-ethnic communities in metropolitan markets in the Eastern U.S., Texas and California. The company provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers, and a variety of other banking services. The majority of its revenue is generated in the form of interest income.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

Share on Social Networks: